Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Sees Significant Drop in Short Interest

Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) saw a large drop in short interest during the month of September. As of September 30th, there was short interest totaling 9,250 shares, a drop of 53.4% from the September 15th total of 19,861 shares. Based on an average daily trading volume, of 6,232 shares, the short-interest ratio is presently 1.5 days. Approximately 0.0% of the shares of the company are short sold.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on AAPG shares. Citigroup initiated coverage on Ascentage Pharma Group International in a report on Tuesday. They issued a “buy” rating and a $46.00 price target for the company. JPMorgan Chase & Co. reduced their price objective on Ascentage Pharma Group International from $46.00 to $33.00 and set an “overweight” rating on the stock in a research note on Thursday, October 8th. BTIG Research reaffirmed a “buy” rating and issued a $48.00 price objective on shares of Ascentage Pharma Group International in a report on Friday, August 21st. Finally, Citizens Jmp began coverage on shares of Ascentage Pharma Group International in a research note on Tuesday. They set a “market outperform” rating and a $35.00 target price for the company. Two equities research analysts have rated the stock with a Strong Buy rating and eleven have assigned a Buy rating to the company’s stock. According to data from MarketBeat, Ascentage Pharma Group International presently has an average rating of “Buy” and a consensus target price of $43.90.

Ascentage Pharma Group International Stock Performance

Shares of Ascentage Pharma Group International stock traded down $0.07 on Thursday, reaching $14.78. 4,549 shares of the company were exchanged, compared to its average volume of 6,807. The company has a quick ratio of 1.18, a current ratio of 1.22 and a debt-to-equity ratio of 1.09. The company’s 50-day moving average is $16.60 and its two-hundred day moving average is $19.17. Ascentage Pharma Group International has a 1-year low of $14.45 and a 1-year high of $37.50.

Ascentage Pharma Group International (NASDAQ:AAPG) last announced its quarterly earnings results on Wednesday, August 19th. The company reported ($0.65) earnings per share (EPS) for the quarter. The company had revenue of $22.24 million during the quarter. On average, equities research analysts forecast that Ascentage Pharma Group International will post -2.42 earnings per share for the current year.

About Ascentage Pharma Group International

Ascentage Pharma Group International is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for cancer and other serious diseases.